Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jeffery Struewing
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Genes & Molecular Sequences
Living Beings
Physiology
Chemicals & Drugs
Procedures
Concepts & Ideas
Phenomena
Sign-in to see full Profile
Network (preview)
22
Tucker, Margaret
12
Sigurdson, Alice
12
Doody, Michele Morin
12
Hartge, Patricia
11
Rutter, Joni
11
Wacholder, Sholom
9
Goldstein, Alisa
9
Alexander, Bruce
9
Brody, Lawrence
8
Greene, Mark
7
Offit, Kenneth
7
Bhatti, Parveen
7
Chetrit, Angela
6
Pineda, Marbin
6
Modan, Baruch
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jeffery Struewing (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Sigurdson Alice J; Bhatti Parveen; Chang Shih-Chen; Rajaraman Preetha; Doody Michele M; Bowen Laura; Simon Steven L; Weinstock Robert M; Linet Martha S; Rosenstein Marvin; Stovall Marilyn; Alexander Bruce H; Preston Dale L; Struewing Jeffery P
Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists.
Breast cancer research and treatment 2009;118(1):177-84.
-
2008: Bhatti Parveen; Doody Michele M; Alexander Bruce H; Yuenger Jeff; Simon Steven L; Weinstock Robert M; Rosenstein Marvin; Stovall Marilyn; Abend Michael; Preston Dale L; Pharoah Paul; Struewing Jeffery P; Sigurdson Alice J
Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(8):2007-11.
-
2008: Chodick Gabriel; Struewing Jeffery P; Ron Elaine; Rutter Joni L; Iscovich Jose
Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.
European journal of medical genetics 2008;51(2):141-7.
-
2008: Bhatti Parveen; Struewing Jeffery P; Alexander Bruce H; Hauptmann Michael; Bowen Laura; Mateus-Pereira Lutecia H; Pineda Marbin A; Simon Steven L; Weinstock Robert M; Rosenstein Marvin; Stovall Marilyn; Preston Dale L; Linet Martha S; Doody Michele M; Sigurdson Alice J
Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists.
International journal of cancer. Journal international du cancer 2008;122(1):177-82.
-
2008: Olshen Adam B; Gold Bert; Lohmueller Kirk E; Struewing Jeffery P; Satagopan Jaya; Stefanov Stefan A; Eskin Eleazar; Kirchhoff Tomas; Lautenberger James A; Klein Robert J; Friedman Eitan; Norton Larry; Ellis Nathan A; Viale Agnes; Lee Catherine S; Borgen Patrick I; Clark Andrew G; Offit Kenneth; Boyd Jeff
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping.
BMC genetics 2008;9():14.
-
2007: Sigurdson Alice J; Bhatti Parveen; Doody Michele M; Hauptmann Michael; Bowen Laura; Simon Steven L; Weinstock Robert M; Linet Martha S; Rosenstein Marvin; Stovall Marilyn; Alexander Bruce H; Preston Dale L; Struewing Jeffrey P; Rajaraman Preetha
Polymorphisms in apoptosis- and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. Radiologic Technologists.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(10):2000-7.
-
2007: Zhang Jinghui; Finney Richard P; Rowe William; Edmonson Michael; Yang Sei Hoon; Dracheva Tatiana; Jen Jin; Struewing Jeffery P; Buetow Kenneth H
Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB).
Genome research 2007;17(7):1111-7.
-
2007: Lönn Stefan; Bhatti Parveen; Alexander Bruce H; Pineda Marbin A; Doody Michele M; Struewing Jeffery P; Sigurdson Alice J
Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologists.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(1):174-7.
-
2007: Pereira Lutécia H Mateus; Pineda Marbin A; Rowe William H; Fonseca Libia R; Greene Mark H; Offit Kenneth; Ellis Nathan A; Zhang Jinghui; Collins Andrew; Struewing Jeffery P
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies.
BMC genetics 2007;8():68.
-
2006: McInerney-Leo Aideen; Hadley Donald; Kase Ronald G; Giambarresi Therese R; Struewing Jeffery P; Biesecker Barbara Bowles
BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening.
American journal of medical genetics. Part A 2006;140(20):2198-206.
-
2006: Bhatti Parveen; Church Deanna M; Rutter Joni L; Struewing Jeffery P; Sigurdson Alice J
Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists.
American journal of epidemiology 2006;164(8):794-804.
-
2006: García-Closas M; Moore L E; Rabkin C S; Franklin T; Struewing J; Ginzinger D; Alguacil J; Rothman N
Quantitation of DNA in buccal cell samples collected in epidemiological studies.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2006;11(5):472-9.
-
2006: Stredrick Denise L; Garcia-Closas Montserrat; Pineda Marbin A; Bhatti Parveen; Alexander Bruce H; Doody Michele M; Lissowska Jolanta; Peplonska Beata; Brinton Louise A; Chanock Stephen J; Struewing Jeffery P; Sigurdson Alice J
The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.
Human mutation 2006;27(6):538-44.
-
2006: García-Closas Montserrat; Egan Kathleen M; Newcomb Polly A; Brinton Louise A; Titus-Ernstoff Linda; Chanock Stephen; Welch Robert; Lissowska Jolanta; Peplonska Beata; Szeszenia-Dabrowska Neonila; Zatonski Witold; Bardin-Mikolajczak Alicja; Struewing Jeffery P
Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses.
Human genetics 2006;119(4):376-88.
-
2006: Spurdle Amanda B; Antoniou Antonis C; Kelemen Livia; Holland Helene; Peock Susan; Cook Margaret R; Smith Paula L; Greene Mark H; Simard Jacques; Plourde Marie; Southey Melissa C; Godwin Andrew K; Beck Jeanne; Miron Alexander; Daly Mary B; Santella Regina M; Hopper John L; John Esther M; Andrulis Irene L; Durocher Francine; Struewing Jeffery P; Easton Douglas F; Chenevix-Trench Georgia;
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(1):76-9.
-
2006: Ellis Nathan A; Kirchhoff Tomas; Mitra Nandita; Ye Tian-Zhang; Chuai Shaokun; Huang Helen; Nafa Khedoudja; Norton Larry; Neuhausen Susan; Gordon Derek; Struewing Jeffery P; Narod Steven; Offit Kenneth
Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping.
Genetic epidemiology 2006;30(1):48-61.
-
2006: Struewing J P; Pineda M A; Sherman M E; Lissowska J; Brinton L A; Peplonska B; Bardin-Mikolajczak A; Garcia-Closas M
Skewed X chromosome inactivation and early-onset breast cancer.
Journal of medical genetics 2006;43(1):48-53.
-
2005: Kramer Joan L; Velazquez Isela A; Chen Bingshu E; Rosenberg Philip S; Struewing Jeffery P; Greene Mark H
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8629-35.
-
2005: Sigurdson Alice J; Hauptmann Michael; Alexander Bruce H; Doody Michele Morin; Thomas Cynthia B; Struewing Jeffery P; Jones Irene M
DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals.
Mutation research 2005;586(2):173-88.
-
2005: McInerney-Leo Aideen; Biesecker Barbara Bowles; Hadley Donald W; Kase Ronald G; Giambarresi Therese R; Johnson Elizabeth; Lerman Caryn; Struewing Jeffery P
BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
American journal of medical genetics. Part A 2005;133A(2):165-9.
-
2004: Wacholder Sholom; Struewing Jeffery P; Hartge Patricia; Greene Mark H; Tucker Margaret A
Breast cancer risks for BRCA1/2 carriers.
Science (New York, N.Y.) 2004;306(5705):2187-91; author reply 2187-91.
-
2004: Rutter Joni L; Bromley Christina M; Goldstein Alisa M; Elder David E; Holly Elizabeth A; Guerry Dupont; Hartge Patricia; Struewing Jeffery P; Hogg David; Halpern Allan; Sagebiel Richard W; Tucker Margaret A
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
Cancer 2004;101(12):2809-16.
-
2004: Mateus Pereira Lutécia H; Sigurdson Alice J; Doody Michele M; Pineda Marbin A; Alexander Bruce H; Greene Mark H; Struewing Jeffery P
CHEK2:1100delC and female breast cancer in the United States.
International journal of cancer. Journal international du cancer 2004;112(3):541-3.
-
2004: McInerney-Leo Aideen; Biesecker Barbara Bowles; Hadley Donald W; Kase Ronald G; Giambarresi Therese R; Johnson Elizabeth; Lerman Caryn; Struewing Jeffery P
BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
American journal of medical genetics. Part A 2004;130A(3):221-7.
-
2004: Struewing Jeffery P; Hartge Patricia; Wacholder Sholom; Tucker Margaret A; Greene Mark H
BRCA1 and sex ratio.
European journal of human genetics : EJHG 2004;12(8):663-7.
-
2004: Goldstein A M; Struewing J P; Fraser M C; Smith M W; Tucker M A
Prospective risk of cancer in CDKN2A germline mutation carriers.
Journal of medical genetics 2004;41(6):421-4.
-
2004: Sigurdson Alice J; Hauptmann Michael; Chatterjee Nilanjan; Alexander Bruce H; Doody Michele Morin; Rutter Joni L; Struewing Jeffery P
Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
BMC cancer 2004;4():9.
-
2004: Baccarelli A; Calista D; Minghetti P; Marinelli B; Albetti B; Tseng T; Hedayati M; Grossman L; Landi G; Struewing J P; Landi M T
XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk.
British journal of cancer 2004;90(2):497-502.
-
2004: Struewing Jeffery P
Genomic approaches to identifying breast cancer susceptibility factors.
Breast disease 2004;19():3-9.
-
2003: Rutter Joni L; Chatterjee Nilanjan; Wacholder Sholom; Struewing Jeffrey
The HER2 I655V polymorphism and breast cancer risk in Ashkenazim.
Epidemiology (Cambridge, Mass.) 2003;14(6):694-700.
-
2003: Haque Kashif A; Pfeiffer Ruth M; Beerman Michael B; Struewing Jeff P; Chanock Stephen J; Bergen Andrew W
Performance of high-throughput DNA quantification methods.
BMC biotechnology 2003;3():20.
-
2003: Kaufman David J; Beaty Terri H; Struewing Jeffery P
Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(10):1045-52.
-
2003: Giusti R M; Rutter J L; Duray P H; Freedman L S; Konichezky M; Fisher-Fischbein J; Greene M H; Maslansky B; Fischbein A; Gruber S B; Rennert G; Ronchetti R D; Hewitt S M; Struewing J P; Iscovich J
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.
Journal of medical genetics 2003;40(10):787-92.
-
2003: Hauptmann Michael; Sigurdson Alice J; Chatterjee Nilanjan; Rutter Joni L; Hill Deirdre A; Doody Michele Morin; Struewing Jeffery P
Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
Journal of the National Cancer Institute 2003;95(16):1251-2.
-
2003: Rutter Joni L; Smith Amelia M; Dávila Michael R; Sigurdson Alice J; Giusti Ruthann M; Pineda Marbin A; Doody Michele M; Tucker Margaret A; Greene Mark H; Zhang Jinghui; Struewing Jeffery P
Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Human mutation 2003;22(2):121-8.
-
2003: Rutter Joni L; Wacholder Sholom; Chetrit Angela; Lubin Flora; Menczer Joseph; Ebbers Sarah; Tucker Margaret A; Struewing Jeffery P; Hartge Patricia
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.
Journal of the National Cancer Institute 2003;95(14):1072-8.
-
2003: Rutter Joni L; Goldstein Alisa M; Dávila Michael R; Tucker Margaret A; Struewing Jeffery P
CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.
Oncogene 2003;22(28):4444-8.
-
2003: Hirsh-Yechezkel G; Chetrit A; Lubin F; Friedman E; Peretz T; Gershoni R; Rizel S; Struewing J P; Modan B
Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel.
Gynecologic oncology 2003;89(3):494-8.
-
2003: Menczer J; Chetrit A; Barda G; Lubin F; Fishler Y; Altaras M; Levavi H; Struewing J P; Sadetzki S; Modan B
Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women.
Gynecologic oncology 2003;88(1):58-61.
-
2002: Zhang Jinghui; Rowe William L; Struewing Jeffery P; Buetow Kenneth H
HapScope: a software system for automated and visual analysis of functionally annotated haplotypes.
Nucleic acids research 2002;30(23):5213-21.
-
2002: Tucker Margaret A; Fraser Mary C; Goldstein Alisa M; Struewing Jeffery P; King Mary A; Crawford John T; Chiazze Ellen A; Zametkin Deborah P; Fontaine Laura S; Clark Wallace H
A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
Cancer 2002;94(12):3192-209.
-
2002: Hartge Patricia; Chatterjee Nilanjan; Wacholder Sholom; Brody Lawrence C; Tucker Margaret A; Struewing Jeffery P
Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.
Epidemiology (Cambridge, Mass.) 2002;13(3):255-61.
-
2002: Ben David Y; Chetrit A; Hirsh-Yechezkel G; Friedman E; Beck B D; Beller U; Ben-Baruch G; Fishman A; Levavi H; Lubin F; Menczer J; Piura B; Struewing J P; Modan B;
Effect of BRCA mutations on the length of survival in epithelial ovarian tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):463-6.
-
2002: Pfeiffer Ruth M; Rutter Joni L; Gail Mitchell H; Struewing Jeffery; Gastwirth Joseph L
Efficiency of DNA pooling to estimate joint allele frequencies and measure linkage disequilibrium.
Genetic epidemiology 2002;22(1):94-102.
-
2001: Wang W W; Spurdle A B; Kolachana P; Bove B; Modan B; Ebbers S M; Suthers G; Tucker M A; Kaufman D J; Doody M M; Tarone R E; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel G H; Chenevix-Trench G; Offit K; Godwin A K; Struewing J P
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(9):955-60.
-
2001: Goldstein A M; Liu L; Shennan M G; Hogg D; Tucker M A; Struewing J P
A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families.
British journal of cancer 2001;85(4):527-30.
-
2001: Modan B; Hartge P; Hirsh-Yechezkel G; Chetrit A; Lubin F; Beller U; Ben-Baruch G; Fishman A; Menczer J; Ebbers S M; Tucker M A; Wacholder S; Struewing J P; Friedman E; Piura B;
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.
The New England journal of medicine 2001;345(4):235-40.
-
2000: Fishman A; Dekel E; Chetrit A; Lerner-Geva L; Bar-Am A; Beck D; Beller U; Ben-Baruch G; Piura B; Friedman E; Struewing J P; Modan B
Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
Gynecologic oncology 2000;79(1):74-8.
-
2000: Biesecker B B; Ishibe N; Hadley D W; Giambarresi T R; Kase R G; Lerman C; Struewing J P
Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
American journal of medical genetics 2000;93(4):257-63.
-
2000: Ciotti P; Struewing J P; Mantelli M; Chompret A; Avril M F; Santi P L; Tucker M A; Bianchi-Scarrà G; Bressac-de Paillerets B; Goldstein A M
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.
American journal of human genetics 2000;67(2):311-9.
-
2000: Goldstein A M; Struewing J P; Chidambaram A; Fraser M C; Tucker M A
Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
Journal of the National Cancer Institute 2000;92(12):1006-10.
-
1999: Struewing J P; Coriaty Z M; Ron E; Livoff A; Konichezky M; Cohen P; Resnick M B; Lifzchiz-Mercerl B; Lew S; Iscovich J
Founder BRCA1/2 mutations among male patients with breast cancer in Israel.
American journal of human genetics 1999;65(6):1800-2.
-
1999: Kaufman D J; Struewing J P
Re: Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history.
Journal of the National Cancer Institute 1999;91(14):1250-1.
-
1999: Sherman M E; Lee J S; Burks R T; Struewing J P; Kurman R J; Hartge P
Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1999;18(2):151-7.
-
1999: Hartge P; Struewing J P; Wacholder S; Brody L C; Tucker M A
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
American journal of human genetics 1999;64(4):963-70.
-
1999: Lee J S; Wacholder S; Struewing J P; McAdams M; Pee D; Brody L C; Tucker M A; Hartge P
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute 1999;91(3):259-63.
-
1998: Thorlacius S; Struewing J P; Hartge P; Olafsdottir G H; Sigvaldason H; Tryggvadottir L; Wacholder S; Tulinius H; Eyfjörd J E
Population-based study of risk of breast cancer in carriers of BRCA2 mutation.
Lancet 1998;352(9137):1337-9.
-
1998: Wacholder S; Hartge P; Struewing J P; Pee D; McAdams M; Brody L; Tucker M
The kin-cohort study for estimating penetrance.
American journal of epidemiology 1998;148(7):623-30.
-
1998: Woodage T; King S M; Wacholder S; Hartge P; Struewing J P; McAdams M; Laken S J; Tucker M A; Brody L C
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews.
Nature genetics 1998;20(1):62-5.
-
1998: Struewing J P
BRCA1 in special populations.
Breast disease 1998;10(1-2):71-5.
-
1998: Ford D; Easton D F; Stratton M; Narod S; Goldgar D; Devilee P; Bishop D T; Weber B; Lenoir G; Chang-Claude J; Sobol H; Teare M D; Struewing J; Arason A; Scherneck S; Peto J; Rebbeck T R; Tonin P; Neuhausen S; Barkardottir R; Eyfjord J; Lynch H; Ponder B A; Gayther S A; Zelada-Hedman M
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
American journal of human genetics 1998;62(3):676-89.
-
1997: Struewing J P; Hartge P; Wacholder S; Baker S M; Berlin M; McAdams M; Timmerman M M; Brody L C; Tucker M A
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
The New England journal of medicine 1997;336(20):1401-8.
-
1997: Abbaszadegan M R; Struewing J P; Brown K M; Snider J V; Goodsaid F; Gore-Langton R; Hughes M R
Automated detection of prevalent mutations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allelic discrimination assay.
Genetic testing 1997;1(3):171-80.
-
1996: Tonin P; Weber B; Offit K; Couch F; Rebbeck T R; Neuhausen S; Godwin A K; Daly M; Wagner-Costalos J; Berman D; Grana G; Fox E; Kane M F; Kolodner R D; Krainer M; Haber D A; Struewing J P; Warner E; Rosen B; Lerman C; Peshkin B; Norton L; Serova O; Foulkes W D; Garber J E
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
Nature medicine 1996;2(11):1179-83.
-
1996: Oddoux C; Struewing J P; Clayton C M; Neuhausen S; Brody L C; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
Nature genetics 1996;14(2):188-90.
-
1996: Struewing J P; Tarone R E; Brody L C; Li F P; Boice J D
BRCA1 mutations in young women with breast cancer.
Lancet 1996;347(9013):1493.
-
1996: Neuhausen S L; Mazoyer S; Friedman L; Stratton M; Offit K; Caligo A; Tomlinson G; Cannon-Albright L; Bishop T; Kelsell D; Solomon E; Weber B; Couch F; Struewing J; Tonin P; Durocher F; Narod S; Skolnick M H; Lenoir G; Serova O; Ponder B; Stoppa-Lyonnet D; Easton D; King M C; Goldgar D E
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
American journal of human genetics 1996;58(2):271-80.
-
1995: Goldstein A M; Fraser M C; Struewing J P; Hussussian C J; Ranade K; Zametkin D P; Fontaine L S; Organic S M; Dracopoli N C; Clark W H
Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
The New England journal of medicine 1995;333(15):970-4.
-
1995: Struewing J P; Abeliovich D; Peretz T; Avishai N; Kaback M M; Collins F S; Brody L C
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.
Nature genetics 1995;11(2):198-200.
-
1995: Struewing J P; Brody L C; Erdos M R; Kase R G; Giambarresi T R; Smith S A; Collins F S; Tucker M A
Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.
American journal of human genetics 1995;57(1):1-7.
-
1995: Struewing J P; Lerman C; Kase R G; Giambarresi T R; Tucker M A
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(2):169-73.
-
1995: Struewing J P; Watson P; Easton D F; Ponder B A; Lynch H T; Tucker M A
Prophylactic oophorectomy in inherited breast/ovarian cancer families.
Journal of the National Cancer Institute. Monographs 1995;(17):33-5.
-
1994: Hussussian C J; Struewing J P; Goldstein A M; Higgins P A; Ally D S; Sheahan M D; Clark W H; Tucker M A; Dracopoli N C
Germline p16 mutations in familial melanoma.
Nature genetics 1994;8(1):15-21.
-
1994: Smith S A; DiCioccio R A; Struewing J P; Easton D F; Gallion H H; Albertsen H; Mazoyer S; Johansson B; Steichen-Gersdorf E; Stratton M
Localisation of the breast-ovarian cancer susceptibility gene (BRCA1) on 17q12-21 to an interval of < or = 1 cM.
Genes, chromosomes & cancer 1994;10(1):71-6.
Sign-in to see more
